BOSS ZHIPIN-W (02076) spent $2.4965 million to repurchase 351,700 shares on May 12th.
BOSS Direct Recruitment-W (02076) announced that the company repurchased 351,700 shares on May 12, 2026, at a total cost of $2.4965 million, with a repurchase price per share ranging from $7.055 to $7.14.
BOSS ZHIPIN-W (02076) announced that the company will spend $2.4965 million to repurchase 351,700 shares on May 12, 2026, at a repurchase price of $7.055-7.14 per share.
Related Articles
InnoCare Pharma (09969): The Phase I clinical trial of ICP-054 (ZB021) has completed the enrollment of the first subject.
MICROTECH MED-B(02235) spent HKD 391,500 to repurchase 50,000 shares on May 13th.
CITIC BANK (00998) will distribute a final dividend of HKD 1.93 for every 10 shares on July 6th.
InnoCare Pharma (09969): The Phase I clinical trial of ICP-054 (ZB021) has completed the enrollment of the first subject.
MICROTECH MED-B(02235) spent HKD 391,500 to repurchase 50,000 shares on May 13th.
CITIC BANK (00998) will distribute a final dividend of HKD 1.93 for every 10 shares on July 6th.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
